Featuring news, events and industry trends

Regeneron Monoclonal Antibody Gets WHO Recommendation for Ebola

Announcing the publication of the first guidelines on treatments for Ebola on Friday, the World Health Organization said that it recommends monoclonal antibodies Inmazeb and Ebanga for the viral disease. The drugs were developed by Tarrytown headquartered Regeneron and Ridgeback Biotherapeutics, respectively.

The decision follows the findings of randomized clinical trials designed to evaluate the therapeutics in Ebola, a severe and often fatal illness caused by the Ebola virus.

The trials were conducted during the disease outbreaks, and the largest trial got underway in the Democratic Republic of the Congo, the WHO said.

Teladoc Health Makes A1C Testing Easier for Members with Diabetes

Purchase headquartered Teladoc Health, the global leader in whole-person care, announced the addition of a home A1C testing program to its Livongo by Teladoc Health chronic care solution, making it easier for members to manage and control their diabetes. Livongo by Teladoc Health members will have the option to receive at-home A1C tests provided by LetsGetChecked, a leading healthcare solutions company that enables providers to administer diagnostics and care directly into the homes of patients. The announcement comes as new company data shows that 58% of members opt for the at-home service when given the chance, with a three to four times greater consumer test return rate than other options on the market.

Design Technologies:  ELabNYC |ABCT |WCBA | Next Prix Galien USA Award Nominee for "Incubators, Accelerators and Equity"

The Galien Foundation, the premier global institution dedicated to honoring innovators in life sciences, today announced the 2022 Prix Galien USA Award nominees for "Best Digital Health Solution," "Incubators, Accelerators and Equity," and "Prix Galien Startup." Among this year’s nominees is Design Technologies, which leads the Westchester County Biosciences Accelerator, among other incubator programs. Winners will be announced during the Prix Galien USA Awards Ceremony on October 27, 2022, at the American Museum of Natural History in New York City.

The newest Prix Galien Award category, "Incubators, Accelerators and Equity," acknowledges the role played by these institutions in guiding the next wave of innovators by offering a range of mentoring skills including clinical trial design expertise, legal counsel, lab space, professional development, peer-to-peer support, free access to leading advisors and economic support to advance life science innovation.


Westchester County Biosciences Accelerator (WCBA) 2022-2023 Program Schedule

WCBA is the first and only competitive-entry, six-month program of personalized entrepreneurial education delivered for first time founders of bioscience ventures of any development stage focused on healthcare innovation in Westchester. WCBA focuses on unlocking the unknown by addressing individual needs and utilizing accredited entrepreneur coaches and expert mentors to craft unique, educational experiences crucial to the development of successful ventures.

The complete education and support program can be found here.


WCBA Info Session

Date: September 2

Time: 12:00 PM



WCBA Info Session

Date: September 5

Time: 12:00 PM


Have good news to share from
Westchester’s bioscience ecosystem?

Please let us know.

If you would like to continue receiving this weekly newsletter,
please sign up below. If you would like to contact us directly, click the Contact Us link.

Facebook  Twitter  Instagram  Linkedin